Transcriptional Control of Intestinal Cytochrome P-4503A by 1 (cid:1) ,25-Dihydroxy Vitamin D 3

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux

  2001cited by this paper
• Increased Vitamin D Receptor Level Enhances 1,25‐Dihydroxyvitamin D3‐Mediated Gene Expression and Calcium Transport in Caco‐2 Cells

  2001influential reference
• YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein.

  2001cited by this paper
• Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

  2001cited by this paper
• Humanized xenobiotic response in mice expressing nuclear receptor SXR

  2000cited by this paper
• Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.

  2000cited by this paper
• The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons.

  2000cited by this paper
• Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

  2000cited by this paper
• The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue.

  1999cited by this paper
• The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module.

  1999cited by this paper
• Sp1 and Egr-1 Have Opposing Effects on the Regulation of the RatPgp2/mdr1b Gene*

  1999cited by this paper
• Cytochrome P-450 3A4: regulation and role in drug metabolism.

  1999cited by this paper
• The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin

  1998cited by this paper
• The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.

  1998influential reference
• SXR, a novel steroid and xenobiotic-sensing nuclear receptor.

  1998influential reference
• Mechanism of vitamin D action and its regulation.

  1998cited by this paper
• Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.

  1998cited by this paper
• Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.

  1997cited by this paper
• Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.

  1997influential reference
• A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.

  1997influential reference
• First‐pass metabolism of midazolam by the human intestine

  1996influential reference
• P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans.

  1996influential reference
• Calcium, vitamin D, and the occurrence of colorectal cancer among women.

  1996cited by this paper
• Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes.

  1996cited by this paper
• Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.

  1996influential reference
• Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism

  1996cited by this paper
• Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.

  1996cited by this paper
• CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines.

  1996cited by this paper
• Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells.

  1994cited by this paper
• Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

  1994cited by this paper
• CYP3A gene expression in human gut epithelium.

  1994cited by this paper
• Aflatoxin B1-adduct formation in rat and human small bowel enterocytes.

  1994cited by this paper
• Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter.

  1994cited by this paper
• Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.

  1994cited by this paper
• Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women.

  1992influential reference
• First-pass metabolism of cyclosporin by the gut.

  1991cited by this paper
• Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation.

  1991influential reference
• Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

  1990cited by this paper
• Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets.

  1988cited by this paper
• Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix

  1988cited by this paper
• Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects.

  1988cited by this paper
• Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues.

  1987cited by this paper
• Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity.

  1987cited by this paper
• The temporal distribution of the 1 alpha,25-dihydroxycholecalciferol receptor in the rat jejunal villus.

  1984cited by this paper
• Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

  1984influential reference
• Characterization of a cytoplasmic receptor-like binder for 1 alpha, 25-dihydroxycholecalciferol in rat intestinal mucosa.

  1979cited by this paper

• Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study

  2023cites this paper
• The Interplay between Vitamin D, Exposure of Anticholinergic Antipsychotics and Cognition in Schizophrenia

  2022cites this paper
• The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia

  2022cites this paper
• Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin–Drug Interactions Exist?

  2022cites this paper
• Molecular Identification and Characterization of Vitamin D Receptor in Grass Carp (Ctenopharyngodon idella)

  2022cites this paper
• Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment.

  2022cites this paper
• Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters

  2022cites this paper
• The Impact of Suboptimal 25‐Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney Disease

  2022cites this paper
• Arsenic: Various species with different effects on cytochrome P450 regulation in humans

  2021cites this paper
• Evaluation system for cell-permeable CYP3A4 inhibitory activity using 1α,25-dihydroxy-vitamin D3-induced intestinal cell lines

  2021cites this paper
• Gutsy science: In vitro systems of the human intestine to model oral drug disposition.

  2021cites this paper
• A Literature Review of the Potential Impact of Medication on Vitamin D Status

  2021cites this paper
• Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study

  2021cites this paper
• Effects of 1α,25-Dihydroxyvitamin D3 on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach

  2021cites this paper
• RMHP_A_316897 3357..3381

  2021cites this paper
• Generation of budding-like intestinal organoids from human induced pluripotent stem cells.

  2021cites this paper
• Characterization of SGLT1-mediated glucose transport in Caco-2 cell monolayers, and absence of its regulation by sugar or epinephrine.

  2021cites this paper
• The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism

  2021cites this paper
• Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

  2020cites this paper
• Impact of CYP3A5 genotype on tolvaptan pharmacokinetics and their relationships with endogenous markers of CYP3A activity and serum sodium level in heart failure patients

  2020cites this paper
• Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities

  2020cites this paper
• Vitamin D and its analogs

  2020cites this paper
• Новые возможности фармакогенетического подхода к персонализированной терапии тамоксифеном (обновлённый систематический обзор)

  2020cites this paper
• Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia

  2020cites this paper
• Characterization Of Cytosolic Sulfotransferase Expression And Regulation In Human Liver And Intestine

  2019cites this paper
• Expression, Regulation und Funktion von Arzneistofftransportern in Caco-2-Zellen: ein biorelevantes in vitro-Modell für den intestinalen Arzneimitteltransport?

  2019cites this paper
• CYP3A suppression during diet-induced nonalcoholic fatty liver disease is independent of PXR regulation.

  2019cites this paper
• Vitamin D Metabolism Revised: Fall of Dogmas

  2019cites this paper
• Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components

  2019influential citation
• Role of vitamin D receptor in the regulation of CYP3A gene expression

  2019cites this paper
• Therapeutic targets of vitamin D receptor ligands and their pharmacokinetic effects by modulation of transporters and metabolic enzymes

  2019cites this paper
• Differential regulation of intestinal and hepatic CYP3A by 1α,25‐dihydroxyvitamin D3: Effects on in vivo oral absorption and disposition of buspirone in rats

  2018cites this paper
• Cryopreserved Human Intestinal Mucosal Epithelium: A Novel In Vitro Experimental System for the Evaluation of Enteric Drug Metabolism, Cytochrome P450 Induction, and Enterotoxicity

  2018cites this paper
• Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression

  2018cites this paper
• Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract

  2018cites this paper
• In vitro effects of rebaudioside A, stevioside and steviol on porcine cytochrome p450 expression and activity.

  2018cites this paper
• A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia

  2018cites this paper
• Role of bile acids in colon carcinogenesis

  2018cites this paper
• Generation of Intestinal Organoids Suitable for Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells

  2018influential citation
• Alterations in gene expression in vitamin D‐deficiency: Down‐regulation of liver Cyp7a1 and renal Oat3 in mice

  2018cites this paper
• Extracts of Immature Orange (Aurantii fructus immaturus) and Citrus Unshiu Peel (Citri unshiu pericarpium) Induce P-Glycoprotein and Cytochrome P450 3A4 Expression via Upregulation of Pregnane X Receptor

  2017cites this paper
• Alterations of Histone Modifications Contribute to Pregnane X Receptor-Mediated Induction of CYP3A4 by Rifampicin

  2017cites this paper
• Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium

  2017cites this paper
• Nuclear Receptor Regulation

  2017cites this paper
• Can Vitamin D Slow Progression of Osteoarthritis

  2017cites this paper
• CYP3A4 is a crosslink between vitamin D and calcineurin inhibitors in solid organ transplant recipients: implications for bone health

  2017cites this paper
• Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.

  2017cites this paper
• Benzophenones and xanthone derivatives from Garcinia schomburgkiana-induced P-glycoprotein overexpression in human colorectal Caco-2 cells via oxidative stress-mediated mechanisms.

  2017cites this paper
• The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells

  2016cites this paper
• Vitamin D Receptor (VDR) and Cholesterol Homeostasis: Interplay of VDR Enzyme Targets and Vitamin D Deficiency

  2016influential citation
• Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Vitamin D Receptor in LS180 Human Colorectal Adenocarcinoma Cells

  2016influential citation
• Vitamin D Nutrient-Gene Interactions and Healthful Aging

  2016cites this paper
• Factors associated with 1,25-dihydroxyvitamin D3 concentrations in liver transplant recipients: a prospective observational longitudinal study

  2016cites this paper
• 1,25-Dihydroxyvitamin D and Klotho: A Tale of Two Renal Hormones Coming of Age.

  2016cites this paper
• RECEPTOROWE MECHANIZMY REGULACJI METABOLIZMU KWASÓW ŻÓŁCIOWYCH I KSENOBIOTYKÓW. ZNACZENIE EKSPRESJI CYP3A4 DLA BEZPIECZEŃSTWA I SKUTECZNOŚCI FARMAKOTERAPII

  2016cites this paper
• Drug–drug interactions that interfere with statin metabolism

  2015cites this paper
• 個別化(オーダーメイド)医療を志向した薬物動態研究および毒性試験へのヒトiPS細胞の利用

  2015cites this paper
• 3-Hydroxyflavone and structural analogues differentially activate pregnane X receptor: Implication for inflammatory bowel disease.

  2015cites this paper
• Vitamin D Receptor-Mediated Upregulation of CYP3A4 and MDR1 by Quercetin in Caco-2 cells

  2015cites this paper
• Calcifediol improves lipid profile in osteopenicatorvastatin‐treated postmenopausal women

  2015cites this paper
• Vitamin D Receptor-Mediated Upregulation of CYP 3 A 4 and MDR 1 by Quercetin in Caco-2 Cells

  2015cites this paper
• Nuclear Receptor-Mediated Regulation of Cytochrome P450 Genes

  2015cites this paper
• Effects of 1α,25-Dihydroxyvitamin D3 on Intestinal Absorption and Disposition of Adefovir Dipivoxil and Its Metabolite, Adefovir, in Rats.

  2015cites this paper
• In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities.

  2015cites this paper
• No Impact of Vitamin D on the CYP3A Biomarker 4β-Hydroxycholesterol in Patients with Abnormal Glucose Regulation

  2015cites this paper
• Microsoft Word-43083131-file00.docx

  2015cites this paper
• Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine

  2015cites this paper
• Dietary modulators of statin efficacy in cardiovascular disease and cognition.

  2014cites this paper
• Rapid Production of Novel Pre-MicroRNA Agent hsa-mir-27b in Escherichia coli Using Recombinant RNA Technology for Functional Studies in Mammalian Cells

  2014influential citation
• Role of the Vitamin D Receptor in MDR1/P-glycoprotein Regulation at the Blood-brain Barrier

  2014cites this paper
• Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.

  2014cites this paper
• Mechanisms and assessment of statin‐related muscular adverse effects

  2014cites this paper
• Stable expression of human VDR in murine VDR‐null cells recapitulates vitamin D mediated anti‐cancer signaling

  2014cites this paper
• Cooperative Regulation of Expression of Cytochrome P450 Enzymes by Aryl Hydrocarbon Receptor and Vitamin D Receptor

  2014cites this paper
• Dietary modi fi cation of metabolic pathways via nuclear hormone receptors

  2013cites this paper
• Interplay between vitamin D and the drug metabolizing enzyme CYP3A4.

  2013cites this paper
• Sunny outlook for personalized medicine: tamoxifen and beyond.

  2013cites this paper
• CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo

  2013cites this paper
• Extrarenal vitamin D activation and interactions between vitamin D₂, vitamin D₃, and vitamin D analogs.

  2013cites this paper
• Corepressors (NCoR and SMRT) as well as coactivators are recruited to positively regulated 1α,25-dihydroxyvitamin D3-responsive genes.

  2013cites this paper
• 1,25-dihydroxyvitamin D in the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma

  2013cites this paper
• Nuclear receptors in bile acid metabolism

  2013cites this paper
• Vitamin D in liver diseases: From mechanisms to clinical trials

  2013cites this paper
• Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer Therapy

  2012cites this paper
• Vitamin D and drug-metabolising enzymes

  2012cites this paper
• Impairment of Bilirubin Clearance and Intestinal Interleukin-6 Expression in Bile Duct-Ligated Vitamin D Receptor Null Mice

  2012cites this paper
• Vitamin D Receptor Activation Enhances Benzo[a]pyrene Metabolism via CYP1A1 Expression in Macrophages

  2012cites this paper
• Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants

  2012cites this paper
• Vitamin D Analogs and Their Clinical Uses

  2012cites this paper
• Animal Models for Studying Drug Metabolizing Enzymes and Transporters

  2012cites this paper
• Dietary modification of metabolic pathways via nuclear hormone receptors

  2012cites this paper
• Vitamin D : Oxidative Stress, Immunity, and Aging

  2012cites this paper
• Effects of 1α,25-dihydroxyvitamin D3 on transport and metabolism of adefovir dipivoxil and its metabolites in Caco-2 cells.

  2012cites this paper
• Vitamin D analogs.

  2012cites this paper
• Vitamin D receptor activation induces peptide YY transcription in pancreatic islets.

  2012cites this paper
• Vitamin D and Cardiovascular Disease

  2012cites this paper
• Vitamin D and colon cancer.

  2012cites this paper
• Vitamin D 25-hydroxylase - Four decades of searching, are we there yet?

  2012cites this paper
• 1α,25‐Dihydroxyvitamin D3‐liganded vitamin D receptor increases expression and transport activity of P‐glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells

  2012cites this paper
• Expression in Macrophages

  2012cites this paper